Heterocycle CDK Inhibitors And Their Use Thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20230265083A1
SERIAL NO

18041223

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The disclosure is directed to, in part, to heterocycle CDK inhibitors, pharmaceutical compositions comprising the same, as well as methods of their use and preparation.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PRELUDE THERAPEUTICS INCORPORATED175 INNOVATION BOULEVARD WILMINGTON DE 19805

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Combs, Andrew P Kennett Square, US 141 5316
Dai, Chaofeng Kennett Square, US 12 29
Leal, Raul A Newark, US 3 0
Lu, Liang Hockessin, US 118 2257

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation